title: Monitoring nutrition therapy in the critically ill patient with obesity.
abstract: Obesity compounds the metabolic response to critical illness and augments the consequences of overfeeding. Effective monitoring is essential for the prevention of, or to avoid, worsening of preexistent morbidities associated with obesity during the implementation of specialized nutrition support. This monitoring should guide the clinician toward the selection of appropriate therapeutic options to reduce complications from significant hyperglycemia, dyslipidemia, hypercapnia, fluid overload, and worsening of hepatic steatosis. Conventional nutrition outcome markers should be employed, with their limitations understood, when used for the critically ill obese patient.
authors.affiliation: Department of Clinical Pharmacy, University of Tennessee Health Science Center, 910 Madison Ave, Memphis, TN 38163, USA. rdickerson@uthsc.edu
authors.forename: Roland N
authors.initials: RN
authors.lastname: Dickerson
authors.forename: John W
authors.initials: JW
authors.lastname: Drover
mesh_terms: D001835:Body Weight; D006332:Cardiomegaly / Q000150:complications / Q000178:diet therapy; D016638:Critical Illness / Q000628:therapy*; D005234:Fatty Liver / Q000150:complications / Q000178:diet therapy; D038321:Glycemic Index / Q000187:drug effects; D006801:Humans; D006935:Hypercapnia / Q000150:complications / Q000178:diet therapy; D006943:Hyperglycemia / Q000150:complications / Q000178:diet therapy; D015228:Hypertriglyceridemia / Q000150:complications / Q000178:diet therapy; D009584:Nitrogen / Q000032:analysis; D065626:Non-alcoholic Fatty Liver Disease; D018529:Nutritional Support / Q000379:methods*; D009765:Obesity / Q000150:complications / Q000178:diet therapy*; D011506:Proteins / Q000032:analysis; D016896:Treatment Outcome
chemical_list: D011506:Proteins; D009584:Nitrogen